USA | Consumer Health & Wellness 1Q'26 EPS First Take: Lower Sales Outlook In Focus Solid start with sales up ~8% and 170k net adds delivering 31% profit growth. However, a weaker consumer and easing premiumization tailwinds lead to a F26 sales outlook reduction (down ~2.5% at mid-point, excl. vet acquisition). Margins were maintained but the return of inflation is a building challenge. Topline cuts rarely occur once, especially in this environment. These pressures offset an otherwise exciting long-term sto ...